Skip to content

Added to your cart:

Cart subtotal

Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)

SKU 78206-0147-01
Sale 24%
Original price $ 2,350.00
Current price $ 1,795.00
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Save 24% ($ 555.00)
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 24%
Original price $ 2,350.00
Current price $ 1,795.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)
Ontruzant Trastuzumab-Dttb Injection 150 mg Cancer Medicine **Refrigeration Required** (RX)
$ 2,350.00 $ 1,795.00
🔒 Medical License Required
Description

Ontruzant Trastuzumab-Dttb Injection 150 mg is a cancer medication used to treat certain types of breast, stomach, and gastroesophageal junction cancers that overexpress the HER2 protein. This injection contains the active ingredient trastuzumab-dttb and belongs to a class of drugs known as monoclonal antibodies. It works by binding to the HER2 protein on cancer cells and blocking their growth and division, ultimately leading to cell death. Ontruzant is biosimilar to the brand-name medication Herceptin, meaning it has been shown to be highly similar in effectiveness and safety profile. It is administered intravenously (into a vein) by a healthcare provider.

Ontruzant Trastuzumab-Dttb belongs to a class of medications known as monoclonal antibodies. It works by binding to a specific protein called HER2 (human epidermal growth factor receptor 2). HER2 is found in high levels on the surface of some cancer cells, including breast and gastric cancers. This protein helps cancer cells grow and spread.

By blocking the function of HER2, Ontruzant Trastuzumab-Dttb slows down the growth and spread of cancer cells. It also stimulates the body's immune system to attack and destroy the cancer cells.

In addition, Ontruzant Trastuzumab-Dttb may work with other chemotherapy medications to further inhibit the growth of cancer cells.

Overall, Ontruzant Trastuzumab-Dttb helps in treating cancers that overexpress HER2 protein, such as breast and gastric cancers.

Get Notified When Back in Stock